ICADE (ICAD.PA) Fundamental Analysis & Valuation

EPA:ICAD • FR0000035081

Current stock price

20.5 EUR
-0.18 (-0.87%)
Last:

This ICAD.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ICAD.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ICAD was profitable.
  • ICAD had a positive operating cash flow in the past year.
  • In multiple years ICAD reported negative net income over the last 5 years.
  • In the past 5 years ICAD always reported a positive cash flow from operatings.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.29%, ICAD is doing worse than 78.05% of the companies in the same industry.
  • ICAD's Return On Equity of -3.17% is on the low side compared to the rest of the industry. ICAD is outperformed by 80.49% of its industry peers.
  • ICAD has a Return On Invested Capital of 2.68%. This is in the lower half of the industry: ICAD underperforms 68.29% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICAD is in line with the industry average of 3.57%.
  • The 3 year average ROIC (2.10%) for ICAD is below the current ROIC(2.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.29%
ROE -3.17%
ROIC 2.68%
ROA(3y)-4.9%
ROA(5y)-2.42%
ROE(3y)-11.54%
ROE(5y)-5.57%
ROIC(3y)2.1%
ROIC(5y)2.36%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • Looking at the Operating Margin, with a value of 19.07%, ICAD is doing worse than 80.49% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ICAD has declined.
  • ICAD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 19.07%
PM (TTM) N/A
GM N/A
OM growth 3Y-18.02%
OM growth 5Y-13.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ICAD.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICAD is destroying value.
  • Compared to 1 year ago, ICAD has about the same amount of shares outstanding.
  • ICAD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ICAD is higher compared to a year ago.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ICAD has an Altman-Z score of 0.69. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ICAD (0.69) is worse than 70.73% of its industry peers.
  • ICAD has a Debt/Equity ratio of 0.92. This is a neutral value indicating ICAD is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.92, ICAD is not doing good in the industry: 70.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACC0.9
WACC2.97%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • ICAD has a Current Ratio of 1.17. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
  • ICAD has a Current ratio of 1.17. This is amongst the best in the industry. ICAD outperforms 82.93% of its industry peers.
  • A Quick Ratio of 0.91 indicates that ICAD may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.91, ICAD is in the better half of the industry, outperforming 78.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.91
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ICAD.PA Growth Analysis

3.1 Past

  • The earnings per share for ICAD have decreased by -6.01% in the last year.
  • The Earnings Per Share has been decreasing by -8.93% on average over the past years.
  • The Revenue has decreased by -7.78% in the past year.
  • The Revenue has been growing slightly by 0.13% on average over the past years.
EPS 1Y (TTM)-6.01%
EPS 3Y-16.16%
EPS 5Y-8.93%
EPS Q2Q%-0.66%
Revenue 1Y (TTM)-7.78%
Revenue growth 3Y-7.23%
Revenue growth 5Y0.13%
Sales Q2Q%-7.28%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.29% on average over the next years.
  • ICAD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.44% yearly.
EPS Next Y-5.17%
EPS Next 2Y-5.65%
EPS Next 3Y-3.29%
EPS Next 5YN/A
Revenue Next Year-7.15%
Revenue Next 2Y-0.34%
Revenue Next 3Y-1.44%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. ICAD.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.90, the valuation of ICAD can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 92.68% of the companies listed in the same industry.
  • ICAD is valuated cheaply when we compare the Price/Earnings ratio to 27.42, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 7.28, which indicates a rather cheap valuation of ICAD.
  • ICAD's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICAD is cheaper than 97.56% of the companies in the same industry.
  • ICAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.29.
Industry RankSector Rank
PE 6.9
Fwd PE 7.28
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • A cheap valuation may be justified as ICAD's earnings are expected to decrease with -3.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.65%
EPS Next 3Y-3.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ICAD.PA Dividend Analysis

5.1 Amount

  • ICAD has a Yearly Dividend Yield of 9.28%, which is a nice return.
  • Compared to an average industry Dividend Yield of 5.38, ICAD pays a better dividend. On top of this ICAD pays more dividend than 95.12% of the companies listed in the same industry.
  • ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 9.28%

5.2 History

  • The dividend of ICAD has a limited annual growth rate of 1.46%.
Dividend Growth(5Y)1.46%
Div Incr Years0
Div Non Decr Years0
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • The earnings of ICAD are negative and hence is the payout ratio. ICAD will probably not be able to sustain this dividend level.
DP-265.61%
EPS Next 2Y-5.65%
EPS Next 3Y-3.29%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

ICAD.PA Fundamentals: All Metrics, Ratios and Statistics

ICADE

EPA:ICAD (4/24/2026, 7:00:00 PM)

20.5

-0.18 (-0.87%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-16
Earnings (Next)07-21
Inst Owners74.92%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.56B
Revenue(TTM)1.45B
Net Income(TTM)-123.00M
Analysts47.27
Price Target21.59 (5.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.28%
Yearly Dividend4.31
Dividend Growth(5Y)1.46%
DP-265.61%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.61%
PT rev (3m)-7.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.66%
EPS NY rev (3m)-8.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.9%
Revenue NY rev (3m)-9.29%
Valuation
Industry RankSector Rank
PE 6.9
Fwd PE 7.28
P/S 1.08
P/FCF N/A
P/OCF 5.2
P/B 0.4
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)2.97
EY14.49%
EPS(NY)2.82
Fwd EY13.74%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)3.94
OCFY19.22%
SpS19.02
BVpS50.86
TBVpS50.4
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.2996 (184.39%)
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -3.17%
ROCE 3.77%
ROIC 2.68%
ROICexc 3.12%
ROICexgc 3.14%
OM 19.07%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.9%
ROA(5y)-2.42%
ROE(3y)-11.54%
ROE(5y)-5.57%
ROIC(3y)2.1%
ROIC(5y)2.36%
ROICexc(3y)2.52%
ROICexc(5y)2.69%
ROICexgc(3y)2.53%
ROICexgc(5y)2.7%
ROCE(3y)2.98%
ROCE(5y)3.38%
ROICexgc growth 3Y1.05%
ROICexgc growth 5Y0.61%
ROICexc growth 3Y1.05%
ROICexc growth 5Y0.6%
OM growth 3Y-18.02%
OM growth 5Y-13.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 21.07%
Interest Coverage 4.05
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.91
Altman-Z 0.69
F-Score6
WACC2.97%
ROIC/WACC0.9
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)17.4%
Cap/Sales(5y)28.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.01%
EPS 3Y-16.16%
EPS 5Y-8.93%
EPS Q2Q%-0.66%
EPS Next Y-5.17%
EPS Next 2Y-5.65%
EPS Next 3Y-3.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.78%
Revenue growth 3Y-7.23%
Revenue growth 5Y0.13%
Sales Q2Q%-7.28%
Revenue Next Year-7.15%
Revenue Next 2Y-0.34%
Revenue Next 3Y-1.44%
Revenue Next 5YN/A
EBIT growth 1Y30.56%
EBIT growth 3Y-23.95%
EBIT growth 5Y-13.02%
EBIT Next Year-5.18%
EBIT Next 3Y-0.25%
EBIT Next 5Y-1.49%
FCF growth 1Y-103.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.01%
OCF growth 3Y-1.35%
OCF growth 5Y-14.31%

ICADE / ICAD.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ICADE (ICAD.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA.


What is the valuation status of ICADE (ICAD.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to ICADE (ICAD.PA). This can be considered as Fairly Valued.


What is the profitability of ICAD stock?

ICADE (ICAD.PA) has a profitability rating of 2 / 10.


What are the PE and PB ratios of ICADE (ICAD.PA) stock?

The Price/Earnings (PE) ratio for ICADE (ICAD.PA) is 6.9 and the Price/Book (PB) ratio is 0.4.


Is the dividend of ICADE sustainable?

The dividend rating of ICADE (ICAD.PA) is 6 / 10 and the dividend payout ratio is -265.61%.